SCPH — Scpharmaceuticals Share News
0.000.00%
Last trade - 00:00- $304.36m
- $314.75m
- $36.33m
U.S. STOCKS ON THE MOVE-Energy firms, gold miners, Analog Devices
scPharmaceuticals falls on pricing $50 mln stock offering
Brief: Scpharmaceuticals Announces Pricing Of $50 Million Public Offering
Brief: ScPharmaceuticals Announces Proposed Underwritten Public Offering Of Common Stock
scPharmaceuticals falls on stock deal
scPharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Brief: Scpharmaceuticals Inc Reports Third Quarter 2022 Financial Results
scPharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: ScPharmaceuticals Says Entered Into Credit Agreement And Guaranty
U.S. FDA approves ScPharmaceuticals' heart failure therapy (updated)
Brief: Scpharmaceuticals Announces $100 Million Debt Financing Agreement With Oaktree
Brief: Scpharmaceuticals Announces FDA Approval Of Furoscix® (Furosemide Injection) For The At-Home Treatment Of Congestion In Chronic Heart Failure
U.S. FDA approves ScPharmaceuticals' heart failure therapy
Brief: Scpharmaceuticals Announces Data Presentations At Heart Failure Society Of America 2022 Annual Scientific Meeting
scPharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: scPharmaceuticals Inc Reports Second Quarter 2022 Financial Results
Brief: Scpharmaceuticals Announces Positive Results From The At Home-Hf Phase 2 Pilot Study In Heart Failure
U.S. RESEARCH ROUNDUP-Helmerich and Payne, J B Hunt Transport Services, Stratasys
scPharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary